Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis
Status:
Recruiting
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
We have to be aware of the challenge and concerns brought by 2019-nCoV to our healthcare
workers. Front-line healthcare workers can become infected in the management of patients with
COVID-19; the high viral load in the atmosphere, and infected medical equipment are sources
for the spread of SARS-CoV-2. If prevention and control measures are not in place, these
healthcare workers are at great risk of infection and become the inadvertent carriers to
patients who are in hospital for other diseases. Nowadays a question that has not yet been
clarified by science has been arises: is hydroxychloroquine associated with zinc compared to
ivermectin associated with zinc effective as a prophylaxis for asymptomatic professionals
involved in the treatment of suspected or confirmed case of COVID-19?
Phase:
N/A
Details
Lead Sponsor:
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara